Oxygenta Pharmaceutical has announced a board meeting following the completion of an open offer through which Virupaksha Organics Limited became the new controlling shareholder, acquiring 55.37% of the company.

The previous promoters and promoter group, holding 6.28% collectively, have been reclassified as public shareholders after transferring their shares.

This shift has led to a change in the company’s management and board composition, marking a significant ownership transition that could influence future strategic decisions and operations.